Golden State Wealth Management »

Aligos Therapeutics shares owned by Golden State Wealth Management

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Golden State Wealth Management from 13F filings

Historical chart of Golden State Wealth Management investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Golden State Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Golden State Wealth Management

Quarter filed Position value Share count Share price at filing
2022-03-31 $36k 17k 2.14
2021-12-31 $176k 15k 11.84
2021-09-30 $230k 15k 15.48
2021-06-30 $303k 15k 20.39
2021-03-31 $337k 15k 22.68
2020-12-31 $411k 15k 27.66

More positions owned by Golden State Wealth Management

Ishares Core MF Closed and MF Open (IVV)
Ishares Core MF Closed and MF Open (AGG)
Apple Common Stock (AAPL)
First Trust MF Closed and MF Open (FVD)
SPDR S&P MF Closed and MF Open (SPY)
Spdr Portfolio MF Closed and MF Open (SPAB)
Invesco Qqq MF Closed and MF Open (QQQ)
Amazon Common Stock (AMZN)
First Trust MF Closed and MF Open (FTCS)
Ishares Msci MF Closed and MF Open (QUAL)
Blackstone Common Stock (BX)
Ishares Msci MF Closed and MF Open (MTUM)
Alphabet Common Stock (GOOGL)
Tesla Common Stock (TSLA)
Principal Us MF Closed and MF Open (USMC)

View all positions for Golden State Wealth Management

Top funds holding Aligos Therapeutics

Armistice Capital
EcoR1 Capital
Deep Track Capital
Vanguard Group
Silverarc Capital Management
BlackRock
State Street Corporation
Tower Research Capital
Two Sigma Investments
HighTower Advisors
Morgan Stanley
Qube Research & Technologies

View all funds holding Aligos Therapeutics